Arkolith/Insider Trading/MLYS/Form 4

Rodman David Malcom

Chief Medical OfficerMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$350K
Net Open-Market Flow
-$350K
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)417$15.44$6K62K
Jun 17, 2026Sell(S)5K$25.00$115K57K
Jun 17, 2026Option exercise(M)4K$14.25$59K61K
Jun 15, 2026Option exercise(M)4K$10.20$36K67K
Jun 15, 2026Sell(S)10K$23.81$235K57K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 17, 2026Option exercise(M)4K—$083K
Jun 17, 2026Option exercise(M)417—$04K
Jun 15, 2026Option exercise(M)4K—$0113K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000094) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML